Mark your calendars: Travera is heading to the Society of Gynecologic Oncology’s Annual Meeting in Seattle, March 14–17. We’ll be sharing our insights on personalized oncology and connecting with physicians, advocates, and researchers. If you’ll be there, let’s chat and explore how our breakthrough MIT-born technology might help more patients. #SGOMtg #precisiononcology #immunotherapy #endometrialcancer #ovariancancer #gynecologiconcology #cervicalcancer #personalizedmedicine #MultiplyYourImpact
关于我们
Travera uses a breakthrough measurement tool invented at MIT to directly measure which cancer drugs are most likely to be effective for each individual cancer patient prior to them taking the drugs. The company offers CLIA certified Rapid Therapy Guidance Tests for all major cancers and 100+ FDA-approved cancer drugs, with a turnaround time of only two days. *See if you qualify for FREE testing through Early Access: https://form.jotform.com/241784594580165
- 网站
-
https://www.travera.com
Travera的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Medford，Massachusetts
- 类型
- 私人持股
- 创立
- 2017
地点
-
主要
获取路线
200 Boston Ave.
1500
US，Massachusetts，Medford，02155
Travera员工
动态
-
The Travera team is gathering today for a full day of strategic meetings, technology deep dives, and a celebratory dinner. We are always excited to brainstorm new ways to advance our Rapid Therapy Guidance Test and collaborate on our novel immune cell assay. Stay tuned for behind-the-scenes highlights! #immunotherapy #precisiononcology #personalizedoncology #traverainc
-
-
Collaboration is key in the fight against cancer. We’re actively looking for research partners—whether you’re focused on ovarian cancer, colon/GI, Lung, or immunotherapy breakthroughs. Let’s connect and explore how we can accelerate progress with our MIT-origin technology and CLIA-certified testing. #checkpointinhibitors #ovariancancer #coloncancer #travera #personalizedmedicine #Personalizedoncology
-
Can a diving board predict cancer drug response? #ovariancancer #cancerawareness #cancertreatment #ovariancancer #coloncancer #coloncancerawareness #PrecisionMedicine #precisiononcology #CANCERSUCKS #ovariancancerawareness
-
Looking forward to this meeting and our opportunity to participate! Worth checking out!
Registration is open for our second in-person scientific conference focusing on Accelerating Biomedical Innovation in Appendiceal Cancer hosted by CANCollaborate to be held at MassBio in Cambridge, MA on October 23rd, 2024. *zoom is available on request We hope you can join?us - agenda and registration link below ?
-
Learn more about Travera's Early Access programs and find out if you qualify at https://lnkd.in/eNSFj3ff ##precisionmedicine #ovariancancerawareness #OvarianCancer #ovarian #precisiononcology #ovariancancer #ovariancancersucks
-
The Travera team is really looking forward to this opportunity.
Did you know there's a way to test live cancer cells from a patient with different FDA-approved drugs to find the most effective treatment? This is what functional precision medicine is all about—delivering quick, personalized insights to help choose the best treatment for each unique cancer. Curious to learn more? We’re exploring the evolution of this field, how it’s changing cancer care today, and the challenges of implementing these tests. Our Ask the Expert session with Travera will be online at Smart Patients from September 9 to 11. To join the conversation, just sign up or sign in. Follow this link to discover how functional precision medicine could change the future of cancer treatment: https://ow.ly/Lehp50T6Rps #ovarian #OvarianCancer #ovariancancer #ovariancancerawareness #ovariancancersucks #precisionmedicine #precisiononcology
-
-
Travera转发了
?? Last chance to submit abstracts for the EHA-SfPM #PrecisionMedicine Meeting! ?? Send your research in by Friday, July 5, in order to showcase it at the first meeting to unite both genomic and functional precision medicine, Find out more here: